All semaglutide doses are now being “continuously shipped” to wholesalers and “meeting or exceeding expected U.S. demand,” Novo Nordisk said in a Friday press release. The company added ...
The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...
Novo Nordisk Cuts Wegovy Prices, Following Similar Move by Zepbound-Maker Eli Lilly Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance ...
Life Where I'm From on MSN27d
Why Most Japanese Clip Art Looks Like ThisHow did Takashi-san's illustrations become Japan's de facto clip art? Watch the vid and find out.
2025-02-20T18:08:30-05:00 https://ximage.c-spanvideo.org ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...
Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...
In response to the Hims & Hers TV ad, Novo Nordisk — the manufacturer of Ozempic and Wegovy — put out a print ad in the New York Times and USA Today stating, “Do you really know what you ...
Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. Of the world’s 22 biopharma companies that had ...
Keeping with healthcare technology for a moment, Clario, a portfolio company of Astorg , Nordic Capital , Cinven and Novo ...
Family Legacy returns on Paramount+ on March 25. By Rania Aniftos The apple doesn’t fall far from the tree, with Paramount+ announcing on Monday (March 3) the return of MTV’s Family Legacy, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results